SeaStar Medical Holding Corp expected to post a loss of 25 cents a share - Earnings Preview
* SeaStar Medical Holding Corp ICU.OQ ICU.O is expected
to report results on August 14 (estimated).
*
* Refinitiv's mean analyst estimate for SeaStar Medical
Holding
Corp is for a loss of 25 cents per share.
* The one available analyst rating on the shares is "buy".
* The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "Buy".
* Wall Street's median 12-month price target for SeaStar
Medical
Holding Corp is $5, above its last closing price of $0.38.
This summary was machine generated August 11 at 13:18 GMT. All
figures in US dollars unless otherwise stated
Recent news on SeaStar Medical Holding
See all newsBrief: FDA Grants Seastar Medical Breakthrough Device Designation For Its Scd Therapy For The Treatment Of Hyperinflammation In Adult Patients With Sepsis Or A Septic Condition
SeaStar Medical Holding Corp reports results for the quarter ended June 30 - Earnings Summary
SeaStar Medical Q2 revenue jumps 82% on QUELIMMUNE demand
Brief: SeaStar Medical Q2 EPS USD -0.91
SeaStar Medical Holding Corp expected to post a loss of 97 cents a share - Earnings Preview